Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Genologica Medica Spain | 100 | 60 |
|
Mitochondrial genome sequencing Molecular Vision Laboratory United States | 526 | 339 |
|
Mitochondrial Panel, Nuclear genes CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 145 | 134 |
|
Spastic paraplegia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 55 | 54 |
|
Oxidative Phosphorylation Disorders NGS Panel Fulgent Genetics United States | 416 | 235 |
|
Hypomyelinating Leukodystrophy NGS Panel Fulgent Genetics United States | 225 | 62 |
|
Familial Spastic Paraplegia , Panel Massive Sequencing (NGS) 22 Genes Reference Laboratory Genetics Spain | 24 | 22 |
|
Autosomal Dominant Familial Spastic Paraplegia , Panel Massive Sequencing (NGS) 9 Genes Reference Laboratory Genetics Spain | 9 | 9 |
|
Hereditary Spastic Paraplegia NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 81 | 79 |
|
SPASTIC PARAPLEGIA, FAMILIAL (AUTOSOMAL DOMINANT) Laboratorio de Genetica Clinica SL Spain | 11 | 11 |
|
Autosomal Dominant Spastic Paraplegia Type 13 , Sequencing HSPD1 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
HSP, Complete Dominant Evaluation Athena Diagnostics United States | 17 | 10 |
|
HSP, Supplemental Sporadic Evaluation Athena Diagnostics United States | 24 | 22 |
|
Athena Diagnostics United States | 40 | 24 |
|
HSP, Supplemental Dominant Evaluation Athena Diagnostics United States | 12 | 6 |
|
Hereditary spastic paraplegia (HSP), autosomal dominant and X-linked Panel CeGaT GmbH Germany | 22 | 17 |
|
Asper Biogene Asper Biogene LLC Estonia | 39 | 38 |
|
Spastic paraplegia 13, autosomal dominant Bioarray Spain | 1 | 1 |
|
Leukodystrophy / Leukencephalopathy and differential diagnoses Panel CeGaT GmbH Germany | 69 | 175 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.